Internship

Intern – R&D Quality

Governance, Risk, & Analytics

Posted on 9/13/2024

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

Compensation Overview

$19 - $55/hr

No H1B Sponsorship

San Mateo, CA, USA

Must be able to relocate if necessary and work at the designated site for the duration of the internship.

Category
Data Science
Data Analysis
Data & Analytics
Required Skills
Data Science
Machine Learning
Data Analysis
Requirements
  • Must be at least 18 years old
  • Must have a minimum GPA of 2.8
  • Authorized to work in the United States without Sponsorship now or in the future or CPT/OPT through your University.
  • Must be currently enrolled as a full-time student at an accredited U.S. based university or college enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
  • Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
  • Must be able to complete a 10-12 consecutive week internship between May and August
  • Must be able to relocate if necessary and work at the designated site for the duration of the internship
Responsibilities
  • Support the creation and execution of new mechanisms to define, measure, and monitor quality performance/quality health of the Quality Management System (QMS) and other areas of quality operations (e.g., Audit, Clinical Quality, etc.)
  • Contributes to the design of data science workflows for the assigned area, incorporating best practice statistical analysis, data engineering, automation and visualization, and other contemporary machine learning techniques, models, and tools
  • Builds, implements, tests, deploys, and maintains innovative data and machine learning solutions to analyze complex data, build insights, and drive innovative process improvements of the QMS
  • Work with complex, structured and unstructured data from a variety of sources and implement machine learning/algorithms to enable detection of signals, trends, and potential areas of risk
  • Contribute to the building of tools and libraries to streamline the data analytics automation efforts and knowledge sharing
  • Showcase your work with a final presentation (PPT) near the conclusion of your internship
Desired Qualifications
  • Preferred Degree qualification: Graduate – PhD
  • Has knowledge in key areas, such as statistical analysis, data automation, data mining and/or data visualization
  • Has advanced knowledge of data science best practices and tools and has experience in applying them to data science solutions
  • Strong knowledge of modern machine learning architectures and platforms
  • Proficiency with MS Office Suite
  • Ability to identify issues and seek solutions
  • Ability to work both independently and collaboratively
  • Demonstrated commitment to inclusion and diversity in the workplace
  • Efficient, organized, and able to handle short timelines in a fast-paced environment

Gilead Sciences is a biopharmaceutical company that develops and sells medicines for various serious health conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then approved by regulatory authorities before being marketed to healthcare providers, hospitals, and pharmacies. Gilead stands out from its competitors by investing heavily in R&D and forming strategic partnerships, such as with SAP Ariba, to improve its supply chain and manufacturing practices. The company's goal is to enhance health equity and access to care, working with communities globally to ensure that its medicines reach those in need.

Company Size

10,001+

Company Stage

IPO

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Lenacapavir's yearly dosage improves patient adherence and outcomes.
  • Partnerships with LEO Pharma and GRYT Health expand Gilead's therapeutic offerings.
  • Manufacturing efficiencies strengthen Gilead's position in CAR-T cell therapy.

What critics are saying

  • AI-driven competitors may erode Gilead's market share and innovation lead.
  • Layoffs could disrupt Gilead's operations and strategic decision-making.
  • Stigma around diseases like lung cancer may hinder market acceptance of treatments.

What makes Gilead Sciences unique

  • Gilead's lenacapavir reformulation offers a once-yearly HIV prevention option.
  • Strategic partnerships enhance Gilead's R&D capabilities and market reach.
  • Gilead's focus on health equity initiatives sets it apart in the biopharma industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Company News

SFist
Apr 2nd, 2025
April Fool's Day Around the Bay: Bob Lee's Family Has Sued His Convicted Killer Nima Momeni

Foster City-based HIV drug company Gilead Sciences is laying off nearly 150 people, and the job cuts are significant among senior members of the company's management.

Labiotech
Mar 27th, 2025
12 Ai Drug Discovery Companies You Should Know About

Newsletter Signup - Under Article / In Page"*" indicates required fields Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the industry now embracing the technology, we take a look at 12 AI drug discovery companies. The COVID-19 pandemic revealed AI to be an essential tool in helping to find treatments and vaccines with greater speed and precision. Since then, there have been several drug discovery breakthroughs for AI within the biopharma industry, from helping to quickly and efficiently discover a new antibiotic called abaucin to combat a multi-drug resistant bacteria, to fully discovering and designing a drug that has entered clinical trials. Here are 12 AI drug discovery companies currently making great strides with their technology. Anima Biotech Technology: mRNA biology modulators Disease areas: Immunology, oncology and neuroscienceRecent news: Announced promising preclinical data for lead pulmonary fibrosis candidate Anima Biotech’s AI drug discovery technology is built around its mRNA Lightning.AI platform, which images hundreds of cellular pathways in both healthy and diseased cells to train disease-specific AI models, making use of neural networks to help these models distinguish between healthy and diseased cells and identify dysregulated pathways. These pathways are subsequently analyzed to uncover novel targets backed by experimental validation. Anima currently has 20 preclinical candidates being evaluated for immunology, oncology, and neuroscience indications, with its most advanced candidate indicated for the treatment of lung fibrosis. The company announced in February 2024 that this candidate had shown promising preclinical results and could open up new avenues for treating patients with idiopathic pulmonary fibrosis. The AI drug discovery company also has ongoing collaborations with several pharma giants. After initially partnering with Eli Lilly in 2018 and Takeda in 2021, its most recent partnership was formed with AbbVie in 2023 for the discovery and development of mRNA biology modulators against oncology and immunology targets. Atomwise Technology: TYK2 inhibitor  Disease area: Autoimmune and autoinflammatory diseasesRecent news: Published results showcasing AtomNet’s ability for drug discoveryAtomwise is leveraging the power of AI in an attempt to revolutionize small molecule drug discovery

Charities.org
Mar 25th, 2025
Sustainability News provided by 3BL

Gilead recently partnered with GRYT Health to host a New Lens on Lung Cancer workshop where people living with lung cancer and their loved ones shared their experience with stigma.

CSR Company
Mar 18th, 2025
Gilead Sciences Ranked in Top Five Most JUST List for Biopharma Companies

Gilead Sciences ranked in top five Most JUST list for biopharma companies.

Pipeline Review
Mar 12th, 2025
First Clinical Data for Gilead's Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

First clinical data for Gilead's investigational Once-Yearly Lenacapavir for HIV Prevention presented at CROI 2025 and published in The Lancet.

INACTIVE